このエントリーをはてなブックマークに追加


ID 71364
フルテキストURL
著者
Oguni, Kohei Department of Infectious Diseases, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Akazawa, Hidemasa Department of Infectious Diseases, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Fukushima, Shinnosuke Department of Infectious Diseases, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Suzuki, Yasuhiro Emergency and Critical Care Center, Kurashiki Central Hospital
Kanai, Katsuki Department of Emergency and Critical Care Medicine, Shimane Prefectural Central Hospital
Haruki, Yuto Department of Pharmacy, Tsuyama Chuo Hospital
Mukuda, Kengo Department of Infectious Diseases and General Internal Medicine, Tottori Prefectural Central Hospital
Matsumoto, Hidemaru Department of Pharmacy, Japanese Red Cross Society Himeji Hospital
Fujihara, Tatsuya Department of General Internal Medicine, Masuda Red-Cross Hospital
Hagiya, Hideharu Department of Infectious Diseases, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences ORCID Kaken ID researchmap
抄録
Background. Invasive group B Streptococcus (GBS) infection in nonpregnant adults is increasing, particularly among older adults and those with underlying comorbidities. However, multicenter data on prognostic factors for adult GBS bacteremia in Japan remain limited.
Methods. We conducted a multicenter retrospective observational cohort study of adults with GBS bacteremia at 7 hospitals in western Japan between 2015 and 2024. Variables analyzed included clinical characteristics, infection sites, microbiological characteristics, and antimicrobial susceptibility profiles. Univariable and multivariable logistic regression analyses were performed to identify factors associated with 30-day mortality.
Results. A total of 442 patients were included. Median age [interquartile range] was 75 [64–84] years, and 83.0% had at least 1 comorbidity. The overall 30-day all-cause mortality for GBS bacteremia was 9.3% (41/442), which rose to 39.3% (11/28) among patients with streptococcal toxic shock syndrome (STSS). In multivariable analysis, STSS was the strongest predictor of death (adjusted odds ratio [aOR], 9.16; 95% confidence interval [CI], 3.28–25.58), followed by immunosuppressive therapy (aOR, 4.62; 95% CI, 1.66–12.86), cirrhosis (aOR, 3.40; 95% CI, 1.23–9.40), respiratory infection (aOR, 3.30; 95% CI, 1.08–10.06), advanced renal dysfunction (aOR, 2.66; 95% CI, 1.09–6.52), and polymicrobial bacteremia (aOR, 2.40; 95% CI, 1.03–5.57), whereas skin and soft tissue infection was associated with lower mortality (aOR, 0.07; 95% CI, 0.01–0.53).
Conclusions. Adult GBS bacteremia carries a high burden of short-term mortality, with a wide variety of clinical presentations, necessitating prompt diagnostic and therapeutic intervention.
キーワード
bacteremia
group B Streptococcus
invasive group B streptococcal disease
streptococcal toxic shock syndrome
streptococcus agalactiae
発行日
2026-09-29
出版物タイトル
Open Forum Infectious Diseases
巻
13巻
号
10号
出版者
Oxford University Press (OUP)
開始ページ
ofag665
ISSN
2328-8957
資料タイプ
学術雑誌論文
言語
英語
OAI-PMH Set
岡山大学
著作権者
© The Author(s) 2026.
論文のバージョン
publisher
DOI
Web of Science KeyUT
関連URL
isVersionOf https://doi.org/10.1093/ofid/ofag665
ライセンス
https://creativecommons.org/licenses/by/4.0/
Citation
Kohei Oguni, Hidemasa Akazawa, Shinnosuke Fukushima, Yasuhiro Suzuki, Katsuki Kanai, Yuto Haruki, Kengo Mukuda, Hidemaru Matsumoto, Tatsuya Fujihara, Hideharu Hagiya, Clinical Characteristics and Mortality Predictors of Group B Streptococcus Bacteremia in Adults: A Multicenter Retrospective Cohort Study in Japan, 2015–2024, Open Forum Infectious Diseases, Volume 13, Issue 10, October 2026, ofag665, https://doi.org/10.1093/ofid/ofag665